By Katherine Hignett2020-06-15T11:55:00
The Department for Health and Social Care paid at least £3.15m on a bulk order of hydroxychloroquine tablets in April for clinical trials, after reportedly spending £2m on the drug in March.
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
Already registered to HSJ? Sign in now
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud